Skip to content

Epidemiology of Inflammatory Bowel Disease in the Songpa-Kangdong District, Seoul, Korea.

Epidemiology of Inflammatory Bowel Disease in the Songpa-Kangdong District, Seoul, Korea.

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT01731665
Enrollment
2000
Registered
2012-11-22
Start date
2012-12-31
Completion date
2029-06-30
Last updated
2021-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Crohn's Disease, Epidemiology, Korea, Ulcerative Colitis

Keywords

Crohn's disease, ulcerative colitis, epidemiology, Korea

Brief summary

The purpose of this study is to evaluate the incidence, prevalence, clinical characteristics and prognosis of Crohn's disease and ulcerative colitis over time in a district of Seoul, Korea.

Detailed description

Inflammatory bowel disease (IBD), which is comprised of Crohn's disease (CD) and ulcerative colitis (UC) is a chronic inflammatory disease of gut with uncertain etiopathogenesis. According to our previous study (Yang, et al. Inflamm Bowel Dis 2008; 14: 542-549), the incidence and prevalence of IBD in Korea are still low compared with those in Western countries, but are rapidly increasing. However, the long-term trends of epidemiology of CD and UC together with their characteristics and prognosis in Korea are uncertain yet. The investigators therefore aim to elucidate the incidence and prevalence of CD and UC over a 30-year period, from 1986 to 2017, in the Songpa-Kangdong district of Seoul, Korea. In addition, the investigators also aim to reveal the clinical features at the time of diagnosis of IBD, long-term evolution of disease and prognosis.

Interventions

None listed

Sponsors

Kyung Hee University Hospital at Gangdong
CollaboratorOTHER
Seoul National University Hospital
CollaboratorOTHER
Seoul National University Bundang Hospital
CollaboratorOTHER
Samsung Medical Center
CollaboratorOTHER
Konkuk University Medical Center
CollaboratorOTHER
National Police Hospital
CollaboratorOTHER_GOV
Seoul Veterans Hospital
CollaboratorOTHER
hansol hospital
CollaboratorUNKNOWN
Kangdong Seoul Clinic
CollaboratorOTHER
Jamsil Seoul Surgical Clinic
CollaboratorUNKNOWN
Song Do Colorectal Hospital
CollaboratorUNKNOWN
Yang Hospital
CollaboratorOTHER
Daehang Hospital
CollaboratorOTHER
Kangdong Sacred Heart Hospital
CollaboratorOTHER
Asan Medical Center
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
OTHER

Eligibility

Sex/Gender
ALL
Healthy volunteers
No

Inclusion criteria

* Definite cases of CD and UC Patients are diagnosed with CD if they meet at least 2 of the following criteria: 1. clinical history of abdominal pain, weight loss, malaise, diarrhea, and/or rectal bleeding 2. endoscopic findings of mucosal cobblestoning, linear ulceration, skip areas, or perianal disease 3. radiologic findings of stricture, fistula, mucosal cobblestoning, or ulceration 4. macroscopic appearance of bowel wall induration, mesenteric lymphadenopathy, and creeping fat at laparotomy 5. pathologic findings of transmural inflammation and/or epithelioid granulomas Only patients who meet these criteria for at least 2 months are included. Patients are diagnosed with UC only if all 3 of the following criteria are present 1. a typical history of diarrhea or blood and pus or both in the stool for longer than 4 weeks 2. a typical sigmoidoscopic or colonoscopic picture with diffusely granular, friable, or ulcerated mucosa without rectal sparing or skip lesions or radiological signs of characteristic continuous granular or ulcerated mucosa 3. characteristic histopathological signs of inflammation on biopsy

Exclusion criteria

* IBD unclassified * Ethnic groups other than Korean

Design outcomes

Primary

MeasureTime frameDescription
Incidence rate and prevalence rate of IBD1986-2017 (up to 31 years)1. Annual incidence rate of Crohn's disease and ulcerative colitis 2. Prevalence rate of Crohn's disease and ulcerative colitis as of Dec 31, 2017.

Secondary

MeasureTime frameDescription
Clinical features of patients with IBD1986-2017 (up to 31 years)1. Clinical characteristics of patients newly diagnosed with Crohn's disease or ulcerative colitis: gender, presenting symptoms, duration between symptoms to diagnosis, and phenotypes, etc. 2. Clinical course of patients newly diagnosed with Crohn's disease or ulcerative colitis: development of complications (strictures, perforations), intestinal resection rate, hospitalization rate, mortality, and pregnancies and their outcomes 3. Treatment modalities of IBD and their trends: use of medication (5-ASA, corticosteroids, immunomodulators, and biologic agents, etc.)

Countries

South Korea

Contacts

Primary ContactSuk-Kyun Yang, M.D.
sky@amc.seoul.kr+82-2-3010-3901
Backup ContactByong Duk Ye, M.D.
bdye@amc.seoul.kr+82-2-3010-3181

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026